blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3137118

EP3137118 - METHODS FOR TREATMENT OF DISORDERS IN THE FRONT OF THE EYE UTILIZING NUCLEIC ACID MOLECULES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  11.11.2022
Database last updated on 07.06.2024
FormerExamination is in progress
Status updated on  02.03.2019
FormerRequest for examination was made
Status updated on  03.02.2017
FormerThe international publication has been made
Status updated on  28.11.2016
Most recent event   Tooltip11.11.2022Application deemed to be withdrawnpublished on 14.12.2022  [2022/50]
Applicant(s)For all designated states
Phio Pharmaceuticals Corp.
257 Simarano Drive, Suite 101
Marlborough, MA 01752 / US
[2019/04]
Former [2017/10]For all designated states
RXi Pharmaceuticals Corporation
257 Simarano Drive, Suite 101
Marlborough, MA 01752 / US
Inventor(s)01 / BYRNE, Michael
8 Loker Street
Natick, MA 01760 / US
02 / PAVCO, Pamela, A.
822 Plateau Road
Longmont, CO 80504 / US
03 / BULOCK, Karen, G.
44 Park Street
Mendon, MA 01756 / US
 [2017/10]
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2017/10]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Application number, filing date15785216.101.05.2015
[2017/10]
WO2015US28860
Priority number, dateUS201461987418P01.05.2014         Original published format: US 201461987418 P
[2017/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015168605
Date:05.11.2015
Language:EN
[2015/44]
Type: A1 Application with search report 
No.:EP3137118
Date:08.03.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 05.11.2015 takes the place of the publication of the European patent application.
[2017/10]
Search report(s)International search report - published on:US05.11.2015
(Supplementary) European search report - dispatched on:EP25.10.2017
ClassificationIPC:C12N15/113, A61K48/00, C07H21/02
[2021/48]
CPC:
C12N15/1137 (EP,US); A61K31/7088 (US); A61P27/02 (EP);
A61P27/04 (EP); A61P29/00 (EP); A61P31/00 (EP);
A61P31/04 (EP); A61P31/22 (EP); A61P43/00 (EP);
C12N15/1136 (EP,US); C12N2310/11 (EP,US); C12N2310/14 (EP,US);
C12N2310/315 (EP,US); C12N2310/321 (EP); C12N2310/322 (EP);
C12N2310/34 (EP); C12N2310/346 (EP,US); C12N2310/351 (EP,US);
C12N2310/3515 (EP,US); C12N2310/3521 (EP); C12N2310/3533 (EP);
C12N2320/32 (EP); C12N2320/51 (EP); C12N2320/52 (EP) (-)
C-Set:
C12N2310/321, C12N2310/3521 (EP,US);
C12N2310/322, C12N2310/3533 (US,EP)
Former IPC [2017/47]A61K48/00, C07H21/02, C12N15/113
Former IPC [2017/10]A61K48/00, C07H21/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/10]
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON STÖRUNGEN VOR DEM AUGE UNTER VERWENDUNG VON NUKLEINSÄUREMOLEKÜLEN[2017/10]
English:METHODS FOR TREATMENT OF DISORDERS IN THE FRONT OF THE EYE UTILIZING NUCLEIC ACID MOLECULES[2017/10]
French:MÉTHODES DESTINÉES À TRAITER LES TROUBLES AFFECTANT L'AVANT DE L' IL FAISANT APPEL À DES MOLÉCULES D'ACIDE NUCLÉIQUE[2017/10]
Entry into regional phase28.11.2016National basic fee paid 
28.11.2016Search fee paid 
28.11.2016Designation fee(s) paid 
28.11.2016Examination fee paid 
Examination procedure28.11.2016Examination requested  [2017/10]
28.11.2016Date on which the examining division has become responsible
17.05.2018Amendment by applicant (claims and/or description)
06.03.2019Despatch of a communication from the examining division (Time limit: M06)
09.09.2019Reply to a communication from the examining division
17.04.2020Despatch of a communication from the examining division (Time limit: M04)
20.08.2020Reply to a communication from the examining division
25.02.2022Despatch of a communication from the examining division (Time limit: M04)
08.07.2022Application deemed to be withdrawn, date of legal effect  [2022/50]
29.07.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2022/50]
Fees paidRenewal fee
30.05.2017Renewal fee patent year 03
29.05.2018Renewal fee patent year 04
28.05.2019Renewal fee patent year 05
27.05.2020Renewal fee patent year 06
27.05.2021Renewal fee patent year 07
27.05.2022Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]WO2010033247  (RXI PHARMACEUTICALS CORP [US], et al) [X] 14 * page 131 - page 133 * * the whole document *[I] 15;
 [Y]WO2011119871  (RXI PHRMACEUTICALS CORP [US], et al) [Y] 1,8-13 * the whole document * * claim - *;
 [XY]  - SRINIWAS SRIRAM ET AL., "Reduction of corneal scarring in rabbits by targeting the TGFB1 pathway with a triple siRNA combination", ADVANCES IN BIOSCIENCE AND BIOTECHNOLOGY, (20130101), vol. 04, no. 10, doi:10.4236/abb.2013.410A4005, ISSN 2156-8456, pages 47 - 55, XP055414374 [X] 2,4-7 * the whole document * [Y] 1,8-13

DOI:   http://dx.doi.org/10.4236/abb.2013.410A4005
 [A]  - SRINIWAS SRIRAM ET AL., "Triple combination of siRNAs Targeting TGF[beta]1, TGF[beta]R2, and CTGF enhances reduction of Collagen I and smooth muscle Actin in corneal fibroblasts", INVESTIGATIVE OPTHALMOLOGY & VISUAL SCIENCE, US, (20131217), vol. 54, no. 13, doi:10.1167/iovs.13-12758, ISSN 1552-5783, page 8214, XP055414366 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1167/iovs.13-12758
 [A]  - HAO J. ET AL., "Gene delivery to cornea", BRAIN RESEARCH BULLETIN, ELSEVIER SCIENCE LTD, OXFORD, GB, vol. 81, no. 2-3, ISSN 0361-9230, (20100215), pages 256 - 261, (20090626), XP026825915 [A] 3-5 * the whole document *
 [A]  - HAO J. ET AL., "Electrically assisted delivery of macromolecules into the corneal epithelium", EXPERIMENTAL EYE RESEARCH, ACADEMIC PRESS LTD, LONDON, vol. 89, no. 6, doi:10.1016/J.EXER.2009.08.001, ISSN 0014-4835, (20091201), pages 934 - 941, (20090812), XP026747515 [A] 3-5 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.exer.2009.08.001
 [X]  - TETSUYA TOYONO ET AL., "Angiopoietin-Like Protein 2 is a potent hemangiogenic and lymphangiogenic factor in corneal inflammation", INVESTIGATIVE OPTHALMOLOGY & VISUAL SCIENCE, US, (20130625), vol. 54, no. 6, doi:10.1167/iovs.12-11497, ISSN 1552-5783, page 4278, XP055414354 [X] 2,3,5,6 * the whole document *

DOI:   http://dx.doi.org/10.1167/iovs.12-11497
 [X]  - HUI GUO ET AL, "Toll-like receptor 2 siRNA suppresses corneal inflammation and attenuates Aspergillus fumigatus keratitis in rats", IMMUNOLOGY AND CELL BIOLOGY, AU, (20110607), vol. 90, no. 3, doi:10.1038/icb.2011.49, ISSN 0818-9641, pages 352 - 357, XP055414709 [X] 2,3,5 * the whole document *

DOI:   http://dx.doi.org/10.1038/icb.2011.49
 [X]  - LI Z. ET AL., "A new approach of delivering siRNA to the cornea and its application for inhibiting herpes simplex keratitis", EMBASE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (20140101), Database accession no. EMB-2015893176, XP002774576 [X] 2,4,5 * the whole document *
 [X]  - LI Z. ET AL., "A new approach of delivering siRNA to the cornea and its application for inhibiting herpes simplex keratitis", CURRENT MOLECULAR MEDICINE 20140101 BENTHAM SCIENCE PUBLISHERS B.V. NLD, (20140101), vol. 14, no. 9, ISSN 1566-5240, pages 1215 - 1225 [X] 2,4,5
International search[A]US2012004045  (RENTZ FELTON [US], et al) [A] 1-4* ; abstract *;
 [X]US2013131142  (LIBERTINE LYN [US], et al) [X] 1-4 * ; abstract; paragraphs [0007], [0008], [0047], [0056], [0248], [0349], [0363], [0365] *
by applicantUS4201860
 US4235871
 US4501728
 US4737323
 US4810646
 US4837028
 US4853386
 US4897355
 WO9014074
 US4992540
 US5013830
 US5028703
 US5032401
 WO9116024
 WO9117424
 US5082936
 WO9203464
 WO9203568
 US5214135
 US5264423
 US5276019
 US5322841
 US5401727
 US5414077
 US5419966
 WO9523162
 US5504079
 US5512667
 US5525719
 US5580972
 US5587469
 US5591843
 US5607677
 US5646126
 US5652359
 WO9813526
 US5736392
 US5767099
 US5777153
 US5780053
 US5789416
 US5830653
 US5830430
 US5849902
 US5851548
 US5855910
 US5968811
 US6020483
 US6242594
 US6331313
 WO0212348
 US6355787
 US6432963
 US6444448
 US6476003
 US2003157030
 US2003216346
 US2004014715
 US2004063654
 US2004072785
 WO2004065601
 US2004162235
 US2005026286
 US2005037496
 US2005042227
 US2005064595
 US2005107325
 US2005265957
 US2005281781
 US2006008910
 WO2006007372
 US7041824
 US2006178327
 US2006240093
 US7205297
 WO2007050643
 US2007231392
 US2008038296
 WO2008021157
 WO2008036825
 US2008107694
 AU2004206255B
 US2008112916
 US2008152661
 WO2009021157
 WO2009102427
 WO2009126933
 WO2009134487
 US2010010082
 US2010040656
 WO2010033247
 US2011039914
 US2012040459
 US2013131142
 US8796443
    - SRIRAM et al., Advances in Bioscience and Biotechnology,, (20130000), vol. 4, no. 10, pages 47 - 55
    - ZUKER, M., Nucleic Acids Res., (20030000), vol. 31, no. 13, pages 3406 - 15
    - MATHEWS, D. H.SABINA, J.ZUKER, M.TURNER, D. H., J. Mol. Biol., (19990000), vol. 288, pages 911 - 940
    - MATHEWS, D. H.DISNEY, M. D.CHILDS, J. L.SCHROEDER, S. J.ZUKER, M.TURNER, D. H., Proc. Natl. Acad. Sci., (20040000), vol. 101, pages 7287 - 7292
    - DUAN, S.MATHEWS, D. H.TURNER, D. H., Biochemistry, (20060000), vol. 45, pages 9819 - 9832
    - WUCHTY, S.FONTANA, W.HOFACKER, I. L.SCHUSTER, P., Biopolymers, (19990000), vol. 49, pages 145 - 165
    - AUGUSTYNS, K. et al., Nucl. Acids. Res., (19920000), vol. 18, page 4711
    - ORTIAGAO et al., Antisense Res. Dev., (19920000), vol. 2, page 129
    - LIANG et al., Pharmazie, (19990000), vol. 54, pages 559 - 566
    - BJERGARDE et al., Nucleic Acids Res., (19910000), vol. 19, page 5843
    - CARUTHERS et al., Nucleosides Nucleotides, (19910000), vol. 10, page 47
    - STEC et al., J. Am. Chem. Soc., (19840000), vol. 106, page 6077
    - STEC et al., J. Org. Chem., (19850000), vol. 50, page 3908
    - STEC et al., J. Chromatog., (19850000), vol. 326, page 263
    - LAPLANCHE et al., Nucl. Acid. Res., (19860000), vol. 14, page 9081
    - BARTZATT, R. et al., Biotechnol. Appl. Biochem., (19890000), vol. 11, page 133
    - LAMONE, Biochem. Soc. Trans., (19930000), vol. 21, page 1
    - KAWASAKI et al., J. Med. Chem., (19930000), vol. 36, page 831
    - UHLMANN et al., Chemical Reviews, (19900000), vol. 90, pages 543 - 584
    - SONVEAUX, "Protecting Groups in Oligonucleotide Synthesis", Agrawal. Methods in Molecular Biology, (19940000), vol. 26, page 1
    - MCNEAL et al., J. Am. Chem. Soc., (19820000), vol. 104, page 976
    - VIARI et al., Biomed. Environ. Mass Spectrom., (19870000), vol. 14, page 83
    - GROTJAHN et al., Nuc. Acid Res., (19820000), vol. 10, page 4671
    - BERGOTEGAN, J. Chrom., (19920000), vol. 599, page 35
    - DNA Cloning, (19850000), vol. I and II
    - T. FISHER et al., Nucleic Acids Research, (19930000), vol. 21, page 3857
    - SHI, Y., Trends Genet, (20030100), vol. 19, page 9
    - REICHHART J M et al., Genesis., (20020000), vol. 34, no. 1-2, page 1604
    - SUI et al., Proc. Natl. Acad Sci. USA, (20020000), vol. 99, page 5515
    - WAGNER E. et al., Proc. Natl. Acad. Sci., (19920000), vol. 88, page 4255
    - SOTOOSTROFF, Bioconjug Chem, (20080000), vol. 19, no. 4, pages 840 - 8
    - "Oral Macrophage Mediated Gene Delivery System", SOTOOSTROFF, Nanotech, (20070000), vol. 2, pages 378 - 381
    - LI et al., "Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88-and Syk kinase-dependent pathways", Clinical Immunology, (20070000), vol. 124, no. 2, doi:10.1016/j.clim.2007.05.002, pages 170 - 181, XP022156792

DOI:   http://dx.doi.org/10.1016/j.clim.2007.05.002
    - VLASSOV et al., Biochimica et Biophysica Acta, (19940000), vol. 1197, pages 95 - 108
    - LEWIS et al., Proc. Natl. Acad. Sci. USA, (19960000), vol. 93, page 3176
    - HOPE et al., Molecular Membrane Biology, (19980000), vol. 15, page 1
    - KAMATA et al., Nucl. Acids. Res., (19940000), vol. 22, page 536
    - LEWIS et al., Proc. Natl. Acad. Sci., (19960000), vol. 93, page 3176
    - MURPHY et al., Proc. Natl. Acad. Sci., (19980000), vol. 95, page 1517
    - ZUCKERMANN, R. N. et al., J. Am. Chem. Soc., (19920000), vol. 114, page 10646
    - ZUCKERMANN, R. N. et al., Int. J. Peptide Protein Res., (19920000), vol. 40, page 497
    - HUNAG et al., Chemistry and Biology, (19980000), vol. 5, page 345
    - LEWIS et al., Proc. Natl. Acad. Sci. US.A., (19960000), vol. 93, page 3176
    - POOGA et al., Nature Biotechnology, (19980000), vol. 16, page 857
    - DEROSSI et al., Trends in Cell Biology., (19980000), vol. 8, page 84
    - ELLIOTTO'HARE, Cell, (19970000), vol. 88, page 223
    - PROCHIANTZ, A., Curr. Opin. Neurobiol., (19960000), vol. 6, page 629
    - DEROSSI et al., Trends Cell Biol., (19980000), vol. 8, page 84
    - TROY et al., J. Neurosci., (19960000), vol. 16, page 253
    - VIVES et al., J. Biol. Chem., (19970000), vol. 272, page 16010
    - PROCHIANTZ., Current Opinion in Neurobiol., (19960000), vol. 6, page 629
    - ALLINQUANT et al., J Cell Biol., (19950000), vol. 128, page 919
    - SMITH et al., Biochem J, (19910000), vol. 276, pages 417 - 2
    - BUNNELL et al., Somatic Cell and Molecular Genetics, (19920000), vol. 18, page 559
    - GINOBBI et al., Anticancer Res., (19970000), vol. 17, page 29
    - CONSTANTINIDES et al., Pharmaceutical Research, (19940000), vol. 11, page 1385
    - HO et al., J. Pharm. Sci., (19960000), vol. 85, pages 138 - 143
    - M. Y. CHIANG et al., JBiol Chem., (19910000), vol. 266, pages 18162 - 71
    - CHEN et al., J. Biol. Chem., vol. 271, page 28259
    - GOULD, S. J.SUBRAMANI, S., Anal. Biochem., (19880000), vol. 7, pages 404 - 408
    - GORMAN C. M.MOFFAT, L. F.HOWARD, B. H., Mol. Cell. Biol., (19820000), vol. 2, pages 1044 - 1051
    - SELDEN, R.BURKE-HOWIE, K.ROWE, M. E.GOODMAN, H. M.MOORE, D. D., Mol. Cell, Biol., (19860000), vol. 6, pages 3173 - 3179
    - KARLINALTSCHUL, Proc. Natl. Acad. Sci. USA, (19900000), vol. 87, pages 2264 - 68
    - KARLINALTSCHUL, Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 5873 - 77
    - ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 10
 US20110613106
 US19610611996
 WO2009US00852
 WO2009US05247
 WO2009US05251
 WO2009US06211
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.